Premier Alternatives

Labviva

Boston, MA · Founded 2017 · Privately Held (backing)

Developer of an AI-powered digital marketplace designed to offer visibility into life science supply chains. Labviva is based in Boston, MA and was founded in 2017. It was valued at $125 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $55.1 million across 2 recorded rounds; the latest was an $8 million early-stage round in Jun 2021.

PMV mark · valuation
$125.0M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$55.1M
Last round
Early Stage VC
Jun 2021

Labviva key facts

as of Oct 2026
  • Developer of an AI-powered digital marketplace designed to offer visibility into life science supply chains.
  • Labviva is valued at approximately $125.0M as of Oct 2026, set at its later-stage round, Dec 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $55.1M across 2 recorded rounds; the latest was Early Stage VC ($8.0M) in Jun 2021.
  • Notable investors include Village Global, B Capital Group, MassVentures, SeedFolio, Glasswing Ventures — 10 tracked in total.
  • Labviva has filed 2 Form Ds with the SEC since 2019, most recently Jun 2021 ($8.0M sold to 3 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$125.0M

Valued at $125.0M at its later-stage round, Dec 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Labviva with a free account
  • ·Watch Labviva: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Labviva funding rounds

2 rounds
Jun 2021Early Stage VC$8.0MSEC filing▮
Apr 2019Seed Round$750KSEC filing▮
Full funding history →

Labviva valuation

Labviva was valued at $125 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Labviva raised?

Labviva has raised $55.1 million in total; 2 of its rounds are on record. The largest on record was an $8 million early-stage round in Jun 2021.

Labviva has filed 2 Form Ds with the SEC since 2019, most recently in Jun 2021 ($8 million sold to 3 investors).

Labviva investors

10 investors are on record for Labviva, including Village Global, B Capital Group, MassVentures and SeedFolio. By type, the record holds 4 venture capital firms and 1 hedge fund. The early-stage round in Jun 2021 drew 3 investors.

About Labviva

Developer of an AI-powered digital marketplace designed to offer visibility into life science supply chains. The company's application works with the existing procurement software and gives insights into everything from lab purchasing trends to supply chain health, enabling clients to preserve their contract pricing with preferred vendors, eliminate the need for third-party fulfillment, and add new direct partnerships without having to maintain separate catalogs.

Sector
Healthcare
HQ
Boston, MA, United States
Founded
2017
Employees
75
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.